Related Experiment Video
Updated: Feb 27, 2026

06:14
In Vivo Protocol of Controlled Subconcussive Head Impacts for the Validation of Field Study Data
Published on: April 18, 2019
7.0K
Evolving concepts of chronic traumatic encephalopathy as a neuropathological entity
H Ling1,2,3, J W Neal4, T Revesz1,2,3
1Queen Square Brain Bank for Neurological Disorders, UCL Institute of Neurology, University College London, London, UK.
Neuropathology and Applied Neurobiology
|July 1, 2017
Summary
Chronic traumatic encephalopathy (CTE) is a neurodegenerative disease from head impacts, diagnosed post-mortem. Recent criteria define CTE by abnormal tau accumulation, but clinical diagnosis remains difficult due to overlapping pathologies and lack of biomarkers.
Area of Science:
- Neuroscience
- Neuropathology
- Sports Medicine
Background:
- Chronic traumatic encephalopathy (CTE) is a progressive neurodegenerative disease linked to repetitive head impacts.
- Definitive diagnosis of CTE has historically been limited to post-mortem examination.
- Recent consensus criteria have refined neuropathological diagnosis, focusing on specific tau protein accumulations.
Purpose of the Study:
- To review the historical development of Chronic Traumatic Encephalopathy (CTE) as a neuropathological entity.
- To highlight recent advancements in understanding and diagnosing CTE.
- To discuss future research directions for CTE.
Main Methods:
- Review of historical literature and neuropathological studies on CTE.
- Analysis of the latest consensus criteria for CTE diagnosis.
- Synthesis of current research findings and identification of knowledge gaps.
Main Results:
- Established the historical evolution of CTE as a distinct neuropathological condition.
- Detailed the mandatory neuropathological features for CTE diagnosis, including tau accumulation patterns.
- Acknowledged the significant challenges in clinical diagnosis and antemortem prediction of CTE.
Conclusions:
- CTE diagnosis relies on specific post-mortem neuropathological findings.
- Clinical diagnosis of CTE is complicated by co-existing neurodegenerative diseases and lack of biomarkers.
- Further research is crucial for developing reliable antemortem diagnostic tools and understanding CTE progression.
Related Concept Videos
Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Disorders of the Nervous Tissue
2.8K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
2.8K
Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K

